TY  - RPRT
TI  - Antibody-drug conjugates against multidrug-resistant cancers: Biomarker-guided patient selection, payload engineering, linker chemistry, and bystander effects.
AU  - Ryan Li
AU  - Xiang Chen
AU  - Qinguo Huang
AU  - Hongjian Ling
AU  - Kunxiang Gong
AU  - Zhe-Sheng Chen
PY  - 2026
DO  - 10.1016/j.canlet.2026.218753
UR  - https://pubmed.ncbi.nlm.nih.gov/42480966/
ID  - 42480966
ER  -